Disorders of Iron Metabolism: New Diagnostic and Treatment Approaches to Iron Deficiency

Jacquelyn M. Powers, George R Buchanan

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Iron deficiency anemia is the leading cause of anemia worldwide and affects many young children and adolescent girls in the United States. Its signs and symptoms are subtle despite significant clinical effects. Iron deficiency anemia is diagnosed clinically by the presence of risk factors and microcytic anemia. Improvement following a trial of oral iron therapy is confirmative. An array of iron laboratory tests is available with variable indications. Clinical trial and iron absorption data support a shift to lower-dose oral iron therapy. Intravenous iron should be considered in children who fail oral iron or who have more complex disorders.

Original languageEnglish (US)
Pages (from-to)393-408
Number of pages16
JournalHematology/Oncology Clinics of North America
Volume33
Issue number3
DOIs
StatePublished - Jun 1 2019

Fingerprint

Iron Metabolism Disorders
Iron
Iron-Deficiency Anemias
Anemia
Therapeutics
Signs and Symptoms
Clinical Trials

Keywords

  • Ferritin
  • Hepcidin
  • Intravenous
  • Iron
  • Oral
  • Therapy

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Disorders of Iron Metabolism : New Diagnostic and Treatment Approaches to Iron Deficiency. / Powers, Jacquelyn M.; Buchanan, George R.

In: Hematology/Oncology Clinics of North America, Vol. 33, No. 3, 01.06.2019, p. 393-408.

Research output: Contribution to journalReview article

@article{8f74b9bf28bb44e1ad9e7b3b8a3828bb,
title = "Disorders of Iron Metabolism: New Diagnostic and Treatment Approaches to Iron Deficiency",
abstract = "Iron deficiency anemia is the leading cause of anemia worldwide and affects many young children and adolescent girls in the United States. Its signs and symptoms are subtle despite significant clinical effects. Iron deficiency anemia is diagnosed clinically by the presence of risk factors and microcytic anemia. Improvement following a trial of oral iron therapy is confirmative. An array of iron laboratory tests is available with variable indications. Clinical trial and iron absorption data support a shift to lower-dose oral iron therapy. Intravenous iron should be considered in children who fail oral iron or who have more complex disorders.",
keywords = "Ferritin, Hepcidin, Intravenous, Iron, Oral, Therapy",
author = "Powers, {Jacquelyn M.} and Buchanan, {George R}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.hoc.2019.01.006",
language = "English (US)",
volume = "33",
pages = "393--408",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Disorders of Iron Metabolism

T2 - New Diagnostic and Treatment Approaches to Iron Deficiency

AU - Powers, Jacquelyn M.

AU - Buchanan, George R

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Iron deficiency anemia is the leading cause of anemia worldwide and affects many young children and adolescent girls in the United States. Its signs and symptoms are subtle despite significant clinical effects. Iron deficiency anemia is diagnosed clinically by the presence of risk factors and microcytic anemia. Improvement following a trial of oral iron therapy is confirmative. An array of iron laboratory tests is available with variable indications. Clinical trial and iron absorption data support a shift to lower-dose oral iron therapy. Intravenous iron should be considered in children who fail oral iron or who have more complex disorders.

AB - Iron deficiency anemia is the leading cause of anemia worldwide and affects many young children and adolescent girls in the United States. Its signs and symptoms are subtle despite significant clinical effects. Iron deficiency anemia is diagnosed clinically by the presence of risk factors and microcytic anemia. Improvement following a trial of oral iron therapy is confirmative. An array of iron laboratory tests is available with variable indications. Clinical trial and iron absorption data support a shift to lower-dose oral iron therapy. Intravenous iron should be considered in children who fail oral iron or who have more complex disorders.

KW - Ferritin

KW - Hepcidin

KW - Intravenous

KW - Iron

KW - Oral

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85063405642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063405642&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2019.01.006

DO - 10.1016/j.hoc.2019.01.006

M3 - Review article

C2 - 31030809

AN - SCOPUS:85063405642

VL - 33

SP - 393

EP - 408

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 3

ER -